跳至主要内容
临床试验/CTRI/2024/08/072781
CTRI/2024/08/072781尚未招募3 期

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Punarnavadi Leha & Argvadhadi Kashaya In The Management Of Dhatvagnimandya W.S.R To Hypothyroidism

Bhanu Priya Choudhary1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年9月2日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
Any changes in the value of serum TSH.

研究概览

简要总结

It is a randomized, prospective, open-label, interventional comparative clinical trial. The trial consists of three groups: one will receive Levothroxin,  the second group will receive both punarnavadi leha and Aragvadhadi Kashaya  and the third group will receive punarnavadi leha. Changes in subjective and objective parameters of Dhatvagnimandhya(Hypothyroidism) will be the endpoint of the study.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • a)Subjects having age between 18 to 60 years of either sex.
  • b)Newly diagnosed patients of TSH level 5-10 mlU/l.
  • c)Patients having any sign and symptom of Dhatwagnimandhya (Hypothyroidism) will be selected for the present study.
  • d)Patient willing to sign the consent form.
  • e)Patient is able to take the medicine properly and follow the Pathya -Apathya f)Patient not taking any other medicine for this disease.

排除标准

  • a)Patients below 18 years and above 60 years of age.
  • b)Patients having TSH level more than 10 or less than
  • c)Patients suffering from any other major acute/ systemic illness viz.
  • Diabetes, HTN, liver disorders etc.
  • d)Pregnant women and lactating mothers.
  • e)Patients undergoing treatment for any other systemic illness.

结局指标

主要结局

Any changes in the value of serum TSH.

时间窗: 3 months

次要结局

  • Assessment of changes in specific symptoms of Dhatwagnimandhya (Hypothyroidism).(3 months)

研究者

发起方
Bhanu Priya Choudhary
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

BHANU PRIYA CHOUDHARY

Madan Mohan Malviya Govt Ayurveda College, Udaipur

研究点 (1)

Loading locations...

相似试验